Abstract:Objective: To assess the clinical value of a radiomics model based on low-dose computed tomography (LDCT) in diagnosing benign and malignant pulmonary ground-glass nodules. Methods: A retrospective analysis was performed on 274 patients who underwent LDCT scanning with the identification of pulmonary ground-glass nodules from January 2018 to March 2021. All patients had complete clinical and pathological data. The cases were randomly divided into 191 cases in a training set and 83 cases in a validation set using the random sampling method and a 7:3 ratio. Based on the predictor sources, we established clinical, radiomics, and combined prediction models in the training set. A receiver operating characteristic (ROC) curve was generated for the training and validation sets, the predictive abilities of the different models for benign and malignant nodules were compared according to the area under the curve (AUC), and the model with the best predictive ability was selected. A calibration curve was plotted to test the good-of-fitness of the model in the validation set. Results: Of the 274 patients (84 males and 190 females), 156 had malignant, and 118 had benign nodules. The univariate analysis showed a statistically significant difference in nodule position between benign nodules and lung adenocarcinoma in both data sets (P <.001 and .021). In the training set, when the nodule diameter was >8 mm, the probability of nodule malignancy increased (P < .001). The results showed that the combined model had a higher prediction ability than the other two models. The combined model could distinguish between benign and malignant pulmonary nodules in the training set (AUC: 0.711; 95%CI: 0.634-0.787; ACC: 0.696; sensitivity: 0.617; specificity: 0.816; PPV:0.835; NPV: 0.585). Moreover, this model could predict benign and malignant nodules in the validation set (AUC: 0.695; 95%CI: 0.574-0.816; ACC: 9.747; sensitivity: 0.694; specificity: 0.824; PPV: 0.850; NPV: 0.651). The calibration curve had a P value of 0.775, indicating that in the validation set, there was no difference between the value predicted by the combined model and the actual observed value and that the result was a good fit. Conclusion: The prediction model combining clinical information and radiomics parameters had a good ability to distinguish benign and malignant pulmonary ground-glass nodules.

Early diagnosis of lung cancer with manifestation of pulmonary ground-glass nodules

Diagnostic Value of Combined High-resolution Computed Tomography and Artificial Intelligence-Aided Diagnosis System in Prediction of Benign and Malignant Pulmonary Ground-Glass Nodules

Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters

Quantitative parameters of HRCT target scan to predict the risk of lung adenocarcinoma based on the detection of lung ground-glass nodules

High-resolution Computed Tomography Findings Independently Predict Epidermal Growth Factor Receptor Mutation Status in Ground-Glass Nodular Lung Adenocarcinoma.

The advances in CT for the diagnosis of pulmonary ground-glass nodules

Clinical, Pathological, and Radiological Characteristics of Solitary Ground-Glass Opacity Lung Nodules on High-Resolution Computed Tomography.

Diagnosing Value of CT-guide Percutaneous Pulmonary Biopsy and Serum Level of Tumor Markers in Diagnosis of Lung Carcinoma

Prediction of the Benign or Malignant Nature of Pulmonary Pure Ground-Glass Nodules Based on Radiomics Analysis of High-Resolution Computed Tomography Images

Assessment of 64-Slice Spiral Computed Tomography with Perfusion Weighted Imaging in the Early Diagnosis of Ground-Glass Opacity Lung Cancer

Ultra-High-Resolution Computed Tomography Findings for Patients with Focal Pulmonary Ground-Glass Nodule of 3 cm or Less

Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer

High-resolution CT in the assessment of lung carcinoma with pulmonary metastasis

Adding Predictive and Diagnostic Values of Pulmonary Ground-Glass Nodules on Lung Cancer Via Novel Non-Invasive Tests

Artificial Intelligence-Aided Diagnosis Software to Identify Highly Suspicious Pulmonary Nodules

The Value of Radiomics Features Based on HRCT in Predicting whether the Lung Sub-Centimeter Pure Ground Glass Nodule is Benign or Malignant

Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules

Diagnosis value of targeted ultra high-resolution CT scanning for pulmonary nodules

Overview of Clinical Progress in Pulmonary Ground-glass Nodules

Multi-slice Spiral CT Features and Prognosis of Pulmonary Ground Glass Nodules

Computer-aided diagnosis of lung cancer: definition and detection of ground-glass opacity type of nodules by high-resolution computed tomography